Abstract
To evaluate TNF-α inhibitor (TNFi) persistence when used as first- or second-line biologic therapy for the management of PsA, and to determine baseline clinical and laboratory parameters associated with TNFi persistence. A retrospective single-centre cohort study was performed on all patients with PsA initiated on TNFi therapy between 2003 and 2015. Demographic, clinical and laboratory characteristics were compared with TNFi persistence, using Kaplan-Meier survival and Cox proportional hazards models. One hundred and eighty-eight patients with PsA were prescribed TNFi therapy as first-line biologic therapy over a period of 635 person-years [46% male, mean (s.d.) age 47.3 (11.4) years; median (interquartile range) disease duration 11 (7-16) years]. At 12 months of follow-up 79% of patients persisted with TNFi therapy, and 73% at 24 months. Of those discontinuing TNFi, 35% stopped due to primary inefficacy, 22% secondary inefficacy and 43% adverse events. Multivariable analysis identified female sex (hazard ratio (HR) 2.57; 95% CI: 1.26, 5.24; P = 0.01) and the presence of metabolic syndrome-related co-morbidities (HR = 2.65, 95% CI: 1.24, 5.69; P = 0.01) as predictors of lower persistence. Of 32 cases treated with a second TNFi,...Continue Reading
References
Jul 13, 2004·Arthritis and Rheumatism·Philip J MeaseWayne Tsuji
Jan 29, 2005·Annals of the Rheumatic Diseases·C AntoniUNKNOWN IMPACT 2 Trial Investigators
Oct 4, 2005·Arthritis and Rheumatism·Philip J MeaseUNKNOWN Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group
Mar 2, 2006·Arthritis Research & Therapy·Juan J Gomez-ReinoUNKNOWN BIOBADASER Group
Apr 20, 2006·Arthritis Research & Therapy·Loreto CarmonaUNKNOWN BIOBADASER Group
Jul 24, 2007·Annals of the Rheumatic Diseases·L E KristensenP Geborek
Feb 2, 2008·Arthritis and Rheumatism·Marte Schrumpf HeibergTore K Kvien
Apr 1, 2009·Arthritis and Rheumatism·Arthur KavanaughAnna Beutler
Apr 10, 2009·Arthritis Research & Therapy·Amr A SaadUNKNOWN British Society for Rheumatology Biologics Register
Feb 1, 2011·Arthritis and Rheumatism·Bente GlintborgMerete Lund Hetland
Feb 13, 2013·Nature Reviews. Rheumatology·Pauline A van SchouwenburgGerrit Jan Wolbink
Apr 9, 2013·Annals of the Rheumatic Diseases·Karen Minde FagerliTore K Kvien
Aug 15, 2013·Annals of the Rheumatic Diseases·P J MeaseD van der Heijde
Aug 29, 2013·Journal of the American Academy of Dermatology·Philip J MeaseDaniel Alvarez
Aug 15, 2014·Annals of the Rheumatic Diseases·Erik H VogelzangCharlotte L M Krieckaert
Nov 15, 2014·Immunologic Research·Luisa CostaRaffaele Scarpa
Nov 17, 2014·The Journal of Rheumatology·Michael ZisapelOri Elkayam
Oct 5, 2015·Lancet·Laura C CoatesPhilip S Helliwell
Jan 29, 2016·RMD Open·Philip J MeaseJeffrey D Greenberg
Sep 22, 2016·Rheumatology·Pil HøjgaardLene Dreyer
Citations
Nov 27, 2018·Journal of Leukocyte Biology·Yaron Ilan
Dec 27, 2018·Pain·Tania Del RiveroJohn R Bethea
Mar 21, 2019·Current Rheumatology Reports·Ippei MiyagawaYoshiya Tanaka
Jan 17, 2019·The Journal of Rheumatology·Alexis OgdiePhilip J Mease
Apr 30, 2019·Expert Review of Clinical Immunology·Carlo Selmi, M Eric Gershwin
Jun 14, 2019·Expert Review of Clinical Immunology·Michael Ruberson Ribeiro da SilvaFrancisco de Assis Acurcio
Oct 31, 2019·Rheumatology·Cecilie Heegaard BraheMerete Lund Hetland
Jan 7, 2020·Expert Review of Clinical Immunology·Ippei Miyagawa, Yoshiya Tanaka
Aug 3, 2019·The Journal of Rheumatology·Elsa Vieira-SousaMaria José Santos
Jan 11, 2020·Frontiers in Pharmacology·Salvatore D'AngeloFrancesco Caso
Apr 21, 2020·Immunological Medicine·Ippei Miyagawa, Yoshiya Tanaka
Jul 20, 2019·Rheumatology International·Philip J MeaseDavid H Collier
Apr 15, 2020·Clinical Rheumatology·A B AzuagaUNKNOWN ESPOCAT group
Oct 8, 2020·Nature Reviews. Rheumatology·Deepak R JadonOliver FitzGerald
Oct 15, 2019·Arthritis Care & Research·Ana-Maria OrbaiLaure Gossec
Dec 17, 2020·Rheumatology·Christine BallegaardLars E Kristensen
Apr 3, 2020·The Journal of Rheumatology·Matthew L ThomasAlison Nightingale
Jan 8, 2021·Rheumatology Advances in Practice·Kirk GealeElke Theander
Jan 11, 2021·Rheumatology International·Sonal GuptaSizheng Steven Zhao
Jan 31, 2021·Arthritis Research & Therapy·Amir HaddadDevy Zisman
Feb 22, 2021·Rheumatology and Therapy·Philipp SewerinJörg Mahlich
Apr 29, 2021·Clinical Rheumatology·Manuel Pombo-SuarezJuan J Gómez-Reino
Jul 1, 2021·Rheumatology International·Lourdes Mateo SoriaAlejandro Olivé-Marqués
Nov 18, 2021·Expert Opinion on Pharmacotherapy·Hasan Tahir, Simran Grewal